The study analyzed the relationship between BRCA1 and BRCA2 single mutation carrying and double mutation carrying with recurrence-free survival, metastasis-free survival, and overall survival in breast cancer patients, which were not associated with clinical factors after adjustment [22]. This evidence concerns the gene BRCA1 and breast carcinoma.